セッション情報

[CINP2024] Spotlight Session

CINP2024 » Spotlight Session

Spotlight Session 3
Recent Topics in Research and Development of Drugs for Treating Neuropsychiatric Disorders

2024年5月24日(金) 15:00 〜 16:00 Room 1 (Hall C)

Chair: Christoph U. Correll (Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA), Tetsuro Kikuchi (Otsuka Pharmaceutical)

+全てマイスケジュールに登録

[SS3-1] Exploring Muscarinic Receptors in Schizophrenia: A Renewed Approach to Developing Innovative Antipsychotics That Go Beyond Dopamine Receptor Antagonism

*Ken Kramer¹ (1. Karuna Therapeutics )

[SS3-2] Brexpiprazole: A Review of the New Treatment Approved for Agitation Associated with Dementia due to Alzheimer‘s Disease

*Malaak Brubaker¹ (1. Otsuka Pharmaceutical Development & Commercialization, Inc.)

[SS3-3] Exploring Innovative Avenues in the Treatment of Alzheimer's Disease

*Teiji Kimura¹ (1. Eisai Co., Ltd.)

認証

要旨・抄録、PDFの閲覧には参加者用アカウントでのログインが必要です。参加者ログイン後に閲覧・ダウンロードできます。
» 参加者用ログイン

▲